SEC Form 4 · accession 0001209191-17-053234
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maky Zanganeh
Director
Period of report
Sep 14, 2017
Accepted (ET)
Sep 18, 2017 · 9:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 14, 2017 | P | 13,000 | $12.2263 | A | 315,725 | D | |
| Common StockF2 | Sep 14, 2017 | P | 9,000 | $13.5486 | A | 324,725 | D | |
| Common StockF3 | Sep 18, 2017 | P | 7,775 | $15.0213 | A | 332,500 | D | |
| Common Stock | holding | — | — | — | 90,474 | I | Dependent Minor |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is the weighted average purchase price of the shares, which ranged from $11.8658 to $12.5499 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F2This is the weighted average purchase price of the shares, which ranged from $12.9397 to $13.88 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F3This is the weighted average purchase price of the shares, which ranged from $14.68 to $15.52 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.